busulfan has been researched along with Endometrial Neoplasms in 1 studies
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
Excerpt | Relevance | Reference |
---|---|---|
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls." | 5.33 | Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005) |
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls." | 1.33 | Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yoshida, M | 1 |
Watanabe, G | 1 |
Shirota, M | 1 |
Maekawa, A | 1 |
Taya, K | 1 |
1 other study available for busulfan and Endometrial Neoplasms
Article | Year |
---|---|
Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Atrophy; Busulfan; Endometrial Neoplasms | 2005 |